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ABSTRACT
Citizens are increasingly crossing borders within the
European Union (EU). Europeans have always been free to
travel to receive care abroad, but if they wished to benefit
from their statutory social protection scheme, they were
subject to their local or national legislation on social
protection. This changed in 1991 with the European Court
of Justice defining healthcare as a service, starting a
debate on the right balance between different principles
in European treaties: movement of persons, goods and
services, versus the responsibility of member states to
organise their healthcare systems. Simultaneously, cross-
border cooperation has developed between member
states.
In this context, patient mobility has become a relevant
issue on the EU’s agenda. The EU funded a number of
Scientific Support to Policies (SSP) activities within the
Sixth Framework Programme, to provide the evidence
needed by EU policy makers to deal with issues that
European citizens face due to enhanced mobility in
Europe. One SSP project ‘‘Methods of Assessing
Response to Quality Improvement Strategies’’
(MARQuIS), focused on cross-border care. It aimed to
assess the value of different quality strategies, and to
provide information needed when: (1) countries contract
care for patients moving across borders; and (2) individual
hospitals review the design of their quality strategies. This
article describes the European context related to
healthcare, and its implications for cross-border health-
care in Europe. The background information demonstrates
a need for further research and development in this area.
The aim of this paper is to describe the European
context related to healthcare, and its implications
for cross-border healthcare in Europe. The back-
ground information demonstrates the need for
further research and development in this area. As a
response to this need, the European Commission
funded the Methods of Assessing Response to
Quality Improvement Strategies (MARQuIS)
research project. This article comprises two main
sections: a description of the European context,
and a description of the MARQuIS project itself.
THE EUROPEAN CONTEXT
Citizens are increasingly crossing borders within
the European Union (EU). The vast majority travel
for reasons unrelated to healthcare. In some cases,
these movements give rise indirectly to demands
on health services, and in others patients may
directly seek specific care services in other member
states.
Europeans have always been free to travel to
receive care in other member states, but if they
wished to benefit from their statutory social
protection scheme, they were subject to their local
or national legislation on social protection.
According to article 22 of Regulation no. 1408/71,
they could benefit from health services in another
European Economic Area country, with access to
emergency care during short-term stays. They
needed, however, prior authorisation for elective
care in another member state since the range of
available benefits was limited to those covered in
the country of insurance.
1 This was challenged in
1991, when the European Court of Justice defined
healthcare as a service.
2 Consequently, in the well-
known Kohll and Decker rulings of 1998, and
subsequent cases, the European Court of Justice
established a new type of cross-border access to
health services in the EU. According to treaty
principles of free movement of persons, goods and
services, citizens should be able to go abroad for
non-hospital care treatment at the expense of their
statutory social protection scheme.
3 Built on
articles 28 and 30 (free movement of goods) and
articles 49 and 50 (free movement of services) of
the treaty, this jurisprudence urges member states
to suppress barriers to fundamental freedoms.
Those new rules apply to social insurance systems
as well as to national health services, according to
the Watts rulings of 16 May 2006.
The above jurisprudence started a debate on the
right balance between different principles in
European treaties: on the one hand, free movement
of people, goods and services, and on the other
hand the responsibility of member states to
organise their healthcare systems. The healthcare
field is essentially guided in the treaties by the rules
of national sovereignty, onto which is grafted the
community principle of subsidiarity:
‘‘the Community only intervenes in those fields
which are not part of its exclusive competence
such as public health, if and to the extent that,
because of their dimension or their effect, the
objectives of the envisaged action would be better
achieved at Community level.’’
Except for particular instances, the level of suitable
administration for a function remains the most
decentralised level. The member states have thus
decided that the state or regional level is the most
appropriate for decisions regarding health.
Consequently, Community actions with regard
to social or health matters are only legitimate if
they add to or strengthen those carried out at the
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Community legislation enacted in the field of health has not
fundamentally transformed the way health systems operate in
the countries of Europe, as the treaties have only given the EU
very tenuous powers over health systems. This reflects the
diversity that is at the very origin of European social systems,
themselves reflected in the differences in the constitutional and
administrative organisation of member states. And this diversity
also holds within countries: the number of states in Europe
which authorise regions to intervene appreciably in the field of
health has markedly increased in the past 30 years. The content
of regional health powers is itself variable. It may be minimal, as
in the implementation of national health legislation and the
management of part of the health system, or maximal, as in
decision-making powers for regulation, health planning, finan-
cing and the supply of hospital care.
With particular reference to hospitals, major differences in
systems may be measured with a few key elements. First, the
means of access to hospitals can be very different from one
member state to another. National hospital structures are also
highly varied, especially in terms of the division between public
and private, and within the private sector, between for-profit
and non-for-profit organisations. As this concerns the burden of
public hospital costs within the national total health budget,
such differences in the organisation of systems cause significant
budgetary differences. On further analysis, it is also clear that
the models of medical organisation, internal management and
decision-making powers in hospitals are very different from one
member state to another.
Convergence is, however, growing for various reasons: cost
containment, innovation, consumerism, ageing, etc. This is
visible in policies for access, quality and financing of hospitals.
The construction of the EU has itself been the basis of a number
of actions, leading to a certain degree of convergence. Legislation
is in place concerning drugs and medical devices, based on free
movement of goods. The mutual recognition of professional
qualifications is also particularly important in the healthcare
sector, as a driving force of convergence. Article 152 of the
Treaty of Amsterdam (1997) widened the powers of the Union
with regard to public health by conferring on it genuine
decision-making powers in certain fields. This is particularly
true with regard to the quality and security of organs and
substances of human origin and blood and its derivatives.
Regardless of increased reimbursement of care made possible
under EU jurisprudence, cross-border cooperation has also
developed between several member states—for example,
Belgium and France, Germany and Luxembourg, and the
Netherlands and the UK.
1 With the financial help of
INTERREG (Innovation & Environment Regions of Europe
Sharing Solutions) programmes, initiatives to improve the social
and economic situation were developed in border regions to
facilitate the administrative procedures, and to extend contracts
for providing benefits-in-kind across borders. Cross-border care
also means mobility of health professionals, and the way this
should be monitored to ensure quality of care.
45
In this context, patient mobility has become a relevant issue
on the EU’s agenda. The need to respond to the jurisprudence of
the European Court of Justice led to the creation of a high-level
process of reflection on patient mobility in 2002 to discuss
issues related to a growing number of patients in specific
situations, including border regions, highly specialised care,
tourists and people residing in another country. A high-level
group on health services and medical care was set up in 2004
to follow developments. Various working groups prepared
concrete proposals for the ministers of health about possible
ways to improve cooperation and exchange of information
between member states at the European level. In this high-level
group, member states have been asked to debate issues of
growing patient mobility, and to focus greater attention on
cross-border healthcare. Some areas for attention thus far have
been the provision of better information systems on spare
capacity across the EU to reduce waiting lists for operations,
conducting joint health technology assessment, creating
European centres of reference for therapies involving advanced
technologies and treatments for rare diseases, and the develop-
ment of a common definition of rights, entitlements, and duties
of patients at the European level.
c In June 2006, the ministers of EU member states approved
the following values and principles for all member state
health services:
c universality (access to healthcare must be ensured for every
person living in the European Union);
c access to good quality care;
c equity (equal access to healthcare regardless of ethnicity,
gender, age, social status and ability to pay)
c solidarity (linked to the financial schemes under which the
health systems are funded).
The principles also state that reducing health inequalities must
be one of the aims of health systems, as well as a shift towards
preventive measures.
Following the exclusion of healthcare services from the
Services Directive adopted in 2006, the European Commission
was asked to work on a strategy for patient mobility that
facilitated progress while respecting national responsibility for
health systems. Again, the issue of the right balance between
free movement and the responsibility of member states to
protect their citizens and organise their healthcare systems was
debated in the consultation process—which should lead to a
directive in this field.
On a global level, trade in health services across borders have
brought mixed benefits.
6 The main concerns are that uncon-
trolled patient choice will damage some national health
systems, treatments abroad will cost more and national
authorities will be unable to regulate rates of treatment and
spending, national health systems will be left with half-empty
institutions, the system overall will become inefficient, medical
staff will migrate across borders, and categories of care and
entitlements will be defined differently internationally.
4
Therefore, if trade in health services is to continue, policy
makers must act to mitigate any adverse consequences and
facilitate the gains.
4
At the same time, healthcare systems in member states face
increasing pressures and demands in terms of universal access to
services, cost containment and sustainability of financing.
7 This
has led to the rapid growth of global interest in the evaluation
of healthcare, due to the increasing need within individual
countries to monitor the use of scarce resources to deliver
healthcare, and the quality of those services.
8 Increasing the
value of health systems requires experimentation and perfor-
mance measurement using actionable and specific indicators,
benchmarking within and across borders, and the sharing of
information, making further work at the international level
imperative.
9 Through international collaboration, experiences
can be exchanged, providing evidence of what works and what
does not, providing the knowledge for evidence-based practice.
10
On the research side, the EU has funded a number of
Scientific Support to Policies (SSP) activities within the Sixth
Framework Programme, with the aim of providing the evidence
Supplement
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citizens face as a result of enhanced mobility in Europe. The
Europe4Patients project (e4p, 2004–7) explored the impact of an
integrated Europe on patients, in terms of the potential benefits
through developments such as greater access to centres of
excellence, and actions that overcome transfrontier imbalances
between demand and supply. The Health Basket project
(2004–7) intended to provide information to national and EU
policy makers on reliable comparisons about available health
services in European member states, how these are defined,
what their costs are and the prices. The MARQuIS research
project we present in this supplement is one of the SSP projects
that focused on cross-border care.
THE MARQUIS PROJECT
Aim and conceptual framework
MARQuIS intends to assess the value of different quality
strategies, and to provide the information needed when
countries contract care for patients moving across borders,
and when individual hospitals review the design of their quality
strategies. The results are intended to provide evidence-based
advice for the further development of formal quality procedures
at the EU level either for healthcare institutions or for
developing existing approaches.
The MARQuIS project has adopted a definition of cross-
border care that includes five categories of mobile patients.
11
Due to the difficulties in identifying the different categories in
current healthcare databases, these five categories have been
defined in descriptive terms for the project as follows:
c citizens who, while on holiday, need to use healthcare
services in the country they are visiting. In these cases, there
are arrangements throughout the European Economic Area
(EEA) to facilitate the process, conferring the right to
treatment during a temporary visit;
c citizens who retire to a different country and wish to use
the healthcare system of the country where they are
currently living;
c people sharing close cultural or linguistic links with the
region where care is provided. This patient group also
includes migrants returning to their country of origin to
receive care;
c patients who cross a border to receive healthcare or to buy
health goods. This is often because of perceived advantages
related to quality, accessibility or prices, specifically out-of-
pocket payments borne by patients;
c patients who are sent abroad by their own health system to
overcome capacity restrictions at home. Some patients cross
borders within the framework of cooperative agreements in
order to share facilities, especially in relation to capital-
intensive or highly specialised services.
To study quality of care in the MARQuIS project we chose
the dimensions of quality of the PATH (Performance
Assessment Tool for Quality Improvement in Hospitals)
conceptual framework, developed by the World Health
Organization (WHO) Regional Office for Europe,
12 since it
provides an up-to-date, comprehensive framework for hospitals,
based on previous existing knowledge. The PATH conceptual
framework advocates a multidimensional approach with six
interrelated dimensions that should be assessed simultaneously.
Two of these dimensions (safety and patient-centredness) cut
across the other four dimensions (clinical effectiveness, effi-
ciency, staff orientation and responsive governance), since they
are inter-related. Figure 1 is a graphical representation of this
framework. The MARQuIS project focuses mainly on the two
central dimensions (safety and patient-centredness) due to their
relevance and inter-relation with the other dimensions, and also
explores clinical effectiveness.
Methods
A multimethod approach involving qualitative and quantitative
methods was chosen, and included literature review, qualitative
studies, questionnaires and visits to centres to verify ques-
tionnaire data and obtain complementary information. To fulfil
its objectives, the MARQuIS project was designed in four
stages, to last for 3 years (2004–7, extended to June 2008). The
information from each stage was to be used as the basis for the
following stage. Figure 2 shows a basic scheme of the stages of
the MARQuIS project.
First stage
The first stage of the project focused on the review and
descriptive analysis of the current situation in Europe regarding,
on the one hand, quality improvement and, on the other hand,
cross-border care. To explore quality improvement, a survey
was conducted of key experts in quality improvement from the
25 EU member states making up the EU in 2005 to gather
information about views and accounts of quality improvement
policies and strategies in different healthcare systems. To
analyse cross-border care, directives of the EU with respect to
patient safety, empowerment and access across borders were
reviewed. Data on foreign admissions were collected to identify
quantity and type of cross-border care occurrence in Europe.
Additional information about this stage is described by Spencer
and Walshe.
13
Second stage
The second stage focused on the identification of key require-
ments for securing patient empowerment and safety in hospital
care. To this end we reviewed some EU directives pertaining to
patient safety, empowerment and access across borders.
Furthermore, a qualitative study with semi-structured inter-
views of patients, professionals and financers was carried out to
explore their views regarding quality requisites—mainly related
to safety and patient-centredness—when receiving or providing
cross-border care.
14 Finally, an exploratory study was done to
Figure 1 Dimensions of quality from the PATH theoretical model for
hospital performance.
14
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that led to hospitalisation of European cross-border patients.
15
Third stage
The third stage of the project built on the information collected
in the two previous stages of the project, and aimed to describe
in a sample of states how hospitals have applied national quality
strategies, how far they meet the defined requirements of cross-
border patients, and what variables of organisation and
methodology are associated with meeting these requirements.
The information was collected during the MARQuIS field test,
which consisted of two main phases. In the first phase a cross-
sectional survey of hospitals was done with a self-administered
questionnaire. In the second phase an on-site audit was done of
a sample of the hospitals that participated in the questionnaire
survey. Both the questionnaire and the audit examined quality
improvement at two levels: hospital management and ward.
Three wards were selected based on the most frequent
diagnoses identified in cross-border care in previous stages of
the project: acute myocardial infarction, deliveries and appen-
dicitis. Eight European countries participated in the field test:
Belgium, Czech Republic, France, Ireland, Poland, Spain, the
Netherlands, and the UK. These countries were selected mainly
based on feasibility characteristics: a national agency with
healthcare assessment experience and a solid reputation in the
country was needed to be able to promote hospital participation
in the study, and to perform assessments of hospitals. The
methods for the field test are described elsewhere.
16 17
Fourth stage
The fourth stage consisted of the aggregation and analyses of
findings from all previous stages in order to draw conclusions
and develop recommendations to policy makers at the EU as
well as the national level. Recommendations for healthcare
organisations and professional organisations were also drawn
from the information and distributed for consultation to
member states and key stakeholders.
18
Results
The MARQuIS project collected self-reported data from 389
hospitals in eight European countries, and included an external
assessment of 89 of these hospitals. In all, the study involved 16
European organisations (universities, accreditation bodies,
scientific societies and federations) related to healthcare quality,
and more than 30 professionals. In addition to the professionals
directly involved in the project, an advisory council of more
than 15 international experts provided recommendations to the
research team. The scientific results and recommendations of
this project are presented here.
CONCLUSION
The successful completion of this project can be considered an
accomplishment in itself. The multinational and multicultural
Figure 2 Scheme of the stages of
MARQuIS project. AMI, acute myocardial
infarction.
Key messages
c Citizens are increasingly crossing borders within the EU
c In the EU, health planning, organisation and delivery are the
responsibility of member states. Intervention by the EU is
based on the principle of subsidiarity, and covers areas such
as public health or legislation on general interest topics such
as drug approval
c In 1991 the European Court of Justice defined healthcare as a
service, and started a debate on the balance between the free
movement of persons, goods and services (established in EU
treaties) versus the responsibility of member states to
organise their healthcare systems
c The EU funded a number of Scientific Support to Policies (SSP)
research projects within the Sixth Framework Programme,
with the aim of providing the evidence needed by EU policy
makers to deal with decisions faced as a result of enhanced
mobility in Europe
c MARQuIS is one such project, which aimed to assess the
value of different quality strategies, and to provide the
information needed when countries contract care for patients
moving across borders, and when individual hospitals review
the design of their quality strategies
c The project involved 389 hospitals in eight countries and
included an audit via on-site visits to 89 of them
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in itself can contribute to self-learning and homogenisation of
the work in different countries. This self-learning and homo-
genisation process seems crucial in the evolving European
context. For this reason the authors advocate the promotion
of further international research focused on the quality of
European healthcare.
Funding: This research was funded by the European Commission through its Scientific
Support to Policies action under the Sixth Framework Programme for Research,
through the Methods of Assessing Response to Quality Improvement Strategies
(MARQuIS) research project (SP21-CT-2004-513712).
Competing interests: None.
REFERENCES
1. Busse R. Border-crossing patients in the EU. Eurohealth 2002;8:19–21.
2. Eur-Lex. Case C-159/90, Society for the Protection of Unborn Children Ireland Ltd v
Stephen Grogan and others, 4 October 1991. Search via http://eur-lex.europa.eu
(accessed 9 Dec 2008).
3. Davies G. Health and efficiency: community law and national health systems in the
light of Mu ¨ller-Faure ´. Modern Law Rev 2004;67:94–107.
4. Tjadens F. Registration and supervision of health professionals in EEA countries.
Maastricht: Netherlands Institute for Care and Welfare, 2004. http://www.nizw.nl/
(accessed 9 Dec 2008).
5. Legido-Quigley H, McKee M, Walshe K, et al. How can quality of health care be
safeguarded across the European Union? BMJ 2008;336:920–3.
6. Chanda R. Trade in health services. Bull World Health Organ 2002;80:158–63.
7. Koivusalo M. European health policies – moving towards markets in health?
Eurohealth 2004;9:18–21.
8. Heidemann EG. Moving to global standards for accreditation processes : the ExPeRT
Project in a larger context. Int J Qual Health Care 2000;12:227–30.
9. Organisation for Economic Co-operation and Development. Towards high-
performing health systems. Summary Report. Paris: The OECD Health Project, 2004.
10. Rolfe MK, Bryar RM, Hjelm K, et al. International collaboration to address common
problems in health care: processes, practicalities and power. Int Nurs Rev
2004;51:140–8.
11. Rosenmo ¨ller M, McKee M, Baeten R. Patient mobility in the European Union. Learning
from experience. Geneva: World Health Organization, 2006, on behalf of the Europe 4
Patients project and the European Observatory on Health Systems and Policies.
12. World Health Organization. Performance assessment tool for quality improvement
in hospitals. Copenhagen: WHO, 2007. http://www.euro.who.int/document/e89742.
pdf (accessed 28 Nov 2008).
13. Spencer E, Walshe K. National quality improvement policies and strategies in
European healthcare systems. Qual Saf Health Care 2009;18(Suppl I):i22–7.
14. Groene O, Poletti P, Vallejo P, et al. Quality requirements for cross-border care in
Europe: a qualitative study of patients’, professionals’ and healthcare financiers’
views. Qual Saf Health Care 2009;18(Suppl I):i15–21.
15. Vallejo P, Sun ˜ol R, Van Beek B, et al. Volume and diagnosis: an approach to cross-
border care in eight European countries. Qual Saf Health Care 2009;18(Suppl I):i8–14.
16. Lombarts MJMH, Rupp I, Vallejo P, et al. Application of quality improvement
strategies in 389 European hospitals: results of the MARQuIS project. Qual Saf Health
Care 2009;18(Suppl I):i28–37.
17. Shaw C, Kutryba B, Crisp H, et al. Do European hospitals have quality and
safety governance systems and structures in place? Qual Saf Health Care
2009;18(Suppl I):i51–6.
18. Groene O, Klazinga N, Walshe K, et al. Learning from MARQuIS: the future direction
of quality and safety in hospital care in the European Union. Qual Saf Health Care
2009;18(Suppl I):i69–74.
Supplement
Qual Saf Health Care 2009;18(Suppl I):i3–i7. doi:10.1136/qshc.2008.029678 i7